Bispecific Antibody Overview & Production with CrossMab Technology

In this webinar, Dr. Sai Wang, protein senior scientist at GenScript Biotech Singapore, will discuss the advantages of bispecific antibodies (bsAbs), their mechanism of action (MOA), and the development history of bsAb platform. She will also help attendees to gain an understanding of the CrossMab production method and its significance in the field of antibody engineering. Additionally, Dr. Wang will provide case studies related to CrossMab production, that offer practical knowledge about the optimization of manufacturing processes of bsAbs.